However, since in addition to the treatment of RA, monoclonal antibodies have been shown to be effective in treating Crohn’s disease, psoriasis, and other diseases associated with TNF-α overexpression, it is possible to compare the results of ASO testing against TNF-α in a model of chronic colitis. Here, TNF is linked to rheumatoid arthritis.